Time is precious in emergency trauma situations, and a new injectable treatment could stop internal bleeding quickly to stabilize patients. Maithili Joshi, a Harvard bioengineering Ph.D. candidate, has developed a peptide that binds to platelets and accelerates clotting. The treatment does not affect normal blood function, and in preclinical models it was found to reduce blood loss by up to 90%. This could change "uncontrollable hemorrhage from a fatal emergency to a survivable injury," said Joshi.